News & Updates

Treatment with the combination of statin and ezetimibe to achieve a low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL works well to consistently reduce the risk of subsequent stroke, according to a post hoc analysis of the Treat Stroke to Target (TST) trial.

Coffee lovers have more reasons to celebrate, with a recent study revealing health benefits from drinking coffee by reducing the risks of many medical conditions, including those in the cardiometabolic and gastrointestinal (GI) systems and those associated with alcohol use and oestrogen regulation.

In the CLASP* IID trial, the PASCAL Transcatheter Valve Repair System demonstrated noninferiority to the MitraClip System for the treatment of severe symptomatic degenerative mitral regurgitation (DMR).

Depending on the model being used, recalibration of risk scores using contemporary population-level data may improve risk stratification for statin therapy, suggests a study.

Once-weekly injection of tirzepatide, a dual GIP and GLP-1 receptor antagonist, slowed eGFR* decline and reduced UACR** in patients with type 2 diabetes (T2D) who are at high risk of cardiovascular (CV) disease compared with once-daily insulin glargine (iGlar), according to a prespecified post hoc analysis of the SURPASS-4*** trial presented at EASD 2022.

Use of aspirin offers health benefits to older individuals with elevated lipoprotein(a) genotypes by preventing cardiovascular events, suggests a study.